Page 8 - டாகேடா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Takeda Pharmaceutical Company Limited Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference Tuesday, January 12, 2021 3:15PM IST (9:45AM GMT)   −  −  Wave 1 Pipeline Portfolio Includes 12 New Molecular Entities Targeted for Launch by FY2024 Representing Best-in-Class/First-in-Class Therapies with Significant Market Potential −  Rapid Deleveraging On Track to Achieve Target of 2x Net Debt / adjusted EBITDA within Fiscal Years 2021 to 2023   Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) provided an update on the progress of its continued transformation and growth today at the virtual 39th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer, Christophe Weber, shared details on Takeda’s portfolio and pipeline strategy and financial outlook, including key programs expected to contribute to the company’s revenue growth over the ne

United statesChristophe weberHolly campbellKazumi kobayashiInternational financial reporting standardsUniversity of texas md anderson cancer centerUs centers for medicare medicaid servicesTakeda pharmaceutical company limitedDrug administrationTakeda pharmaceutical companyExchange commissionJapanese ministry of healthPortfolio includesMolecular entities targetedFirst in class therapiesSignificant market